Cambridge Epigenetix has launched a discovery and development program for a test to detect colorectal and other cancers

Cambridge Epigenetix Developing CRC Test Using $30M Financing

New CEO Suman Shirodkar, PhD, to oversee development of diagnostic designed to analyze the epigenetic modification 5hmC in cfDNA
Source: © olly/Fotolia

Dako, Amgen Expand Cancer CDx Collaboration

Dako, an Agilent Technologies company specializing in providing cancer diagnostics, said today it has again expanded a three-year-old collaboration with Amgen focused on companion...
Source: University of Helsinki

The Broad’s Mark Daly Recruited to Lead Institute for Molecular Medicine Finland

Daly will spearhead FIMM's FinnGen biobank genetic project with a goal of collecting genomic information of 500,000 Finns by 2023.
Source: Cultura RF/Michael J. Klein

MolecularMD, Genoptix Enter Exclusive Marketing Agreement for Tasigna CDx

MolecularMD's MRDx BCR-ABL CDx identifies CML patients being treated with Tasigna for initiation and monitoring of treatment-free remission
Amoy Diagnostics (AmoyDx) will partner with CANbridge Life Sciences to develop a companion diagnostic for CANbridge’s lead candidate

AmoyDx to Develop CDx for CANbridge Glioblastoma Candidate

CAN008 is now under study in a Phase I/II trial in GBM patients in Taiwan, with plans to launch a Phase II trial in glioblastoma in China.
Quest Diagnostics says its planned acquisition of MedFusion and Clear Point will enable it to accelerate its growth in cancer diagnostics. [iStock/jarun011]

Quest Diagnostics Acquires 2 Texas Labs, Creates Precision Medicine Cancer Dx Center

Quest's acquisition creates specialized cancer diagnostics center to provide tumor sequencing, and other genomic and pathology testing.
Source: Ugreen/Getty Images

FDA Clears SeptiCyte LAB for Suspected Sepsis Patients

Immunexpress granted 510(k) clearance for its novel diagnostic in differentiating sepsis from SIRS in critical patients.
Source: Steve Prezant/Getty Images

Epigenetic Changes from Lack of Sleep Linked with Weight Gain

Just one night of sleep loss triggers epigenetic, gene expression, and metabolic changes linked to muscle mass loss and an increase in fat
Prostate cancer, illustration

Myriad to Pursue mCRPC Approval for BRACAnalysis CDx

Myriad Genetics said today it will pursue FDA authorization of its BRACAnalysis CDx test as a companion diagnostic for the AstraZeneca/Merck & Co. co-marketed...

Study Shows Natera Test Faster than Imaging in Detecting Colorectal Cancer Recurrence

Natera’s Signatera test has shown potential in a newly-published survey for guiding treatment decisions after surgery by identifying colorectal cancer recurrence at an average...
Scroll Up